Hui Dong

Hui Dong

Auto-generated profile, based on publicly available information

Hui Dong

Peking University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in Nature Methods
Verified
Journal Article
Closed access
PDF file
YZYizhou Zhuo
Yizhou Zhuo
BLBin Luo
Bin Luo
XYXinyang Yi
Xinyang Yi
HDHui Dong
Hui Dong
XMXiaolei Miao
Xiaolei Miao
YLYulong Li
Yulong Li

5 March 2024 in Nature Methods
Verified
Journal Article
Closed access
PDF file
FDFei Deng
Fei Deng
JWJinxia Wan
Jinxia Wan
GLGuochuan Li
Guochuan Li
HDHui Dong
Hui Dong
XXXiju Xia
Xiju Xia
YLYulong Li
Yulong Li

1 November 2020 in Brain
Verified
Journal Article
Closed access
YSYan Shen
Yan Shen
WYWen-Bo Yu
Wen-Bo Yu
BSBo Shen
Bo Shen
HDHui Dong
Hui Dong
JZJue Zhao
Jue Zhao
Jian WangJian Wang
Jian Wang
Idiopathic rapid eye movement sleep behaviour disorder (RBD) is now recognized as an early manifestation of α-synucleinopathies. Increasing experimental studies demonstrate that manipulative lesion or inactivation of the neurons within the sublaterodorsal tegmental nucleus (also known as the subcoeruleus nucleus in humans) can induce RBD-like behaviours in animals. As current RBD animal models are not established on the basis of α-synucleinopathy, they do not represent the pathological substrate of idiopathic RBD and thus cannot model the phenoconversion to Parkinson’s disease. The purpose of this study was therefore to establish an α-synucleinopathy-based RBD animal model with the potential to convert to parkinsonian disorder. To this end, we first determined the functional neuroanatomical location of the sublaterodorsal tegmental nucleus in wild-type C57BL/6J mice and then validated its function by recapitulating RBD-like behaviours based on this determined nucleus. Next, we injected preformed α-synuclein fibrils into the sublaterodorsal tegmental nucleus and performed regular polysomnographic recordings and parkinsonian behavioural and histopathological studies in these mice. As a result, we recapitulated RBD-like behaviours in the mice and further showed that the α-synucleinopathy and neuron degeneration identified within the sublaterodorsal tegmental nucleus acted as the neuropathological substrates. Subsequent parkinsonian behavioural studies indicated that the α-synucleinopathy-based RBD mouse model were not stationary, but could further progress to display parkinsonian locomotor dysfunction, depression-like disorder, olfactory dysfunction and gastrointestinal dysmotility. Corresponding to that, we determined α-synuclein pathology in the substantia nigra pars compacta, olfactory bulb, enteral neuroplexus and dorsal motor nucleus of vagus nerve, which could underlie the parkinsonian manifestations in mice. In conclusion, we established a novel α-synucleinopathy-based RBD mouse model and further demonstrated the phenoconversion of RBD to Parkinson’s disease in this animal model.

28 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
WLWenkai Lin
Wenkai Lin
LXLingyu Xu
Lingyu Xu
YZYanrong Zheng
Yanrong Zheng
SASile An
Sile An
MZMengting Zhao
Mengting Zhao
ZCZhong Chen
Zhong Chen
Histamine is a conserved neuromodulator in mammalian brains and critically involved in many physiological functions. Understanding the precise structure of the histaminergic network is the cornerstone in elucidating its function. Herein, using histidine decarboxylase (HDC)-CreERT2 mice and genetic labeling strategies, we reconstructed a whole-brain three dimensional (3D) structure of histaminergic neurons and their outputs at 0.32 × 0.32 × 2 μm 3 pixel resolution with a cutting-edge fluorescence microoptical sectioning tomography system. We quantified the fluorescence density of all brain areas and found that histaminergic fiber density varied significantly among brain regions. The density of histaminergic fiber was positively correlated with the amount of histamine release induced by optogenetic stimulation or physiological aversive stimulation. Lastly, we reconstructed a fine morphological structure of 60 histaminergic neurons via sparse labeling and uncovered the largely heterogeneous projection pattern of individual histaminergic neurons. Collectively, this study reveals an unprecedented whole-brain quantitative analysis of histaminergic projections at the mesoscopic level, providing a foundation for future functional histaminergic study.

5 June 2025 in Science
Verified
Journal Article
Closed access
YZYu Zheng
Yu Zheng
RCRuyi Cai
Ruyi Cai
KWKui Wang
Kui Wang
JZJunwei Zhang
Junwei Zhang
YZYizhou Zhuo
Yizhou Zhuo
YLYulong Li
Yulong Li
Dopamine (DA) plays a crucial role in a variety of brain functions through intricate interactions with other neuromodulators and intracellular signaling pathways. However, studying these complex networks has been hindered by the challenge of detecting multiple neurochemicals in vivo simultaneously. To overcome this limitation, we developed a single-protein chemigenetic DA sensor, HaloDA1.0, which combines a cpHaloTag–chemical dye approach with the G protein–coupled receptor activation–based (GRAB) strategy, providing high sensitivity for DA, subsecond response kinetics, and a far-red to near-infrared spectral range. When used together with existing green and red fluorescent neuromodulator sensors, calcium indicators, cyclic adenosine 5′-monophosphate sensors, and optogenetic tools, HaloDA1.0 showed high versatility for multiplex imaging in cultured neurons, brain slices, and behaving animals, facilitating in-depth studies of dynamic neurochemical networks.

16 August 2021 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
YYYan‐Fei Yang
Yan‐Fei Yang
HDHui Dong
Hui Dong
YSYan Shen
Yan Shen
LLLei Li
Lei Li
Michael LazarusMichael Lazarus
Michael Lazarus
Zhi-Li HuangZhi-Li Huang
Zhi-Li Huang